Award
NIH Reporter #PAR-21-321
Translational Oncology Research Program
Recipient
National Cancer Institute (NCI), part of the National Institutes of Health (NIH)
Award Amount
$37,947.00
Ceiling
$37,947.00
Awarded
July 20, 2026
Identifier
PAR-21-321
Award for translational oncology research to develop new anticancer agents and conduct clinical trials, funded by NIH/NCI with approximately $37,947.
Description
The project focuses on translational oncology research aimed at identifying novel targets, developing new anticancer agents, and leading clinical trials to reduce cancer incidence and mortality, particularly in Kentucky. The project involves collaboration among multiple investigators and institutions, with a focus on precision medicine and biomarker development.